Gateway Health Alliances will present new clinical research demonstrating its patented botanical extracts increase circulating GLP-1 activity during an industry webinar hosted by SupplySide Supplement Journal on April 28.

Shil Kothari explores how new clinical research on two of the company’s botanical ingredients helps reframe the conversation around GLP-1s for formulators and brands.

An AgFunderNews article highlights Gateway Health Alliances as a rare botanical ingredient supplier with human clinical data directly linked to GLP-1 biology.

Gateway Health Alliances today announced the peer-reviewed publication in Medicina of updated clinical results showing that its patented botanical extracts, Dyglomera® (Dichrostachys glomerata) and CQR-300® (Cissus quadrangularis), significantly increased natural GLP-1 levels by inhibiting DPP-4 activity.

Fairfield, CA – October 8, 2025 – Gateway Health Alliance President Shil Kothari will join a panel discussion focused on developing healthy, natural solutions to fill nutrition and metabolic wellness gaps emerging in the era of GLP-1s.